SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-523701
Filing Date
2016-03-30
Accepted
2016-03-30 16:02:25
Documents
62
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d105545d10k.htm 10-K 846520
2 EX-23 d105545dex23.htm EX-23 1796
3 EX-31 d105545dex31.htm EX-31 7663
4 EX-32 d105545dex32.htm EX-32 3132
11 GRAPHIC g105545tx_pg37.jpg GRAPHIC 66974
  Complete submission text file 0001193125-16-523701.txt   5788280

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20151231.xml EX-101.INS 1092355
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20151231.xsd EX-101.SCH 68946
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20151231_cal.xml EX-101.CAL 54527
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20151231_def.xml EX-101.DEF 251082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20151231_lab.xml EX-101.LAB 511473
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20151231_pre.xml EX-101.PRE 382228
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36457 | Film No.: 161539559
SIC: 2834 Pharmaceutical Preparations